09 May, EOD - Indian

SENSEX 79454.47 (-1.10)

Nifty 50 24008 (-1.10)

Nifty Bank 53595.25 (-1.42)

Nifty IT 35880.1 (-0.34)

Nifty Midcap 100 53223.35 (-0.01)

Nifty Next 50 62527 (-0.37)

Nifty Pharma 21071.75 (-0.21)

Nifty Smallcap 100 16085.65 (-0.61)

09 May, EOD - Global

NIKKEI 225 37503.33 (1.56)

HANG SENG 22867.74 (0.40)

S&P 5696 (-0.01)

LOGIN HERE

companylogoSai Life Sciences Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 544306 | NSE Symbol : SAILIFE | ISIN : INE570L01029 | Industry : Pharmaceuticals - Indian - Formulations |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
24-Mar-2025 24-Mar-2025 Change in Directors Appointment of Dr. Dinesh V Patel (DIN: 11010657) as Additional Director of the Company under the category of Independent Director With reference to the Intimation for Allotment dated 24.03.2025. Please find the attached revised Intimation for allotment on conversion of ESOPs into Equity.
24-Jan-2025 06-Feb-2025 Quarterly Results Sai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that a Meeting of the Board of Directors of the Company will be held on Thursday 06 February 2025 to consider and approve inter alia the following: 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31 December 2024 Further pursuant to Companys Code of Conduct for prohibition of Insider Trading the trading window for transacting in the securities of the company was closed from 01 January 2025 and will remain closed till 08 February 2025 for the Directors / officials and designated persons of the Company Pursuant to Regulation 30, 33 and any other provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, the Board of Directors of the Company, at its meeting held on Thursday, 06 February 2025, inter-alia considered and approved the following: 1. Un-audited Financial Results (Standalone and Consolidated) of the Company and noted the Limited Review Reports of the Statutory Auditors, M/s. Deloitte Haskins & Sells LLP for the quarter and nine months ended 31 December 2024. A copy of the same are enclosed herewith as Annexure. The Meeting of the Board of Directors was duly commenced at 6.30 PM (IST) and concluded at 9.15 PM (IST). (As Per Bse Announcement Dated on 06.02.2025)

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +